Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA Chmp Approval Recommendation Under New Tailored Clinical Approach PR Newswire (Press Release) 12:59 Tue, 22 Sep
Bespak expands next-gen nasal offering with launch of NasaDose European Pharmaceutical Manufacturer 17h
Sanofi and Regeneron expand immunology partnership to the tune of $8bn Pharmaceutical Technology 19h Sanofi Regeneron Biotech
Regeneron, Sanofi Extend Dupixent Playbook With Four Next-Gen Immunology Antibodies Scrip Pharma Intelligence 1d Sanofi Regeneron Biotech
